Literature

_________________________________________________________________

Reviews

Berezin et al: NCAM mimetic peptides: Pharmacological and therapeutic potential. J Mol Neurosci 2004;22:33-39.

 

Ezzat S et al: The molecular pathogenetic role of cell adhesion in endocrine neoplasia. J Clin Pathol 2005;58:1121-1125.

 

Grose R et al: Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Rev 2005;16:179-186.

 

Sandi C: Stress, cognitive impairment and cell adhesion molecules. Nat Rev Neurosci 2004;5:917-930.

 

Walmod PS et al: Zippers make signals: NCAM-mediated molecular interactions and signal transduction. Neurochem Res 2004;29:2015-2035.

 

FGL specific literature

Cambon K et al: A synthetic neural cell adhesion molecule mimetic peptide promotes synaptogenesis, enhances presynaptic function, and facilitates memory consolidation. J Neurosci 2004;24:4197-4204.

 

Kiselyov VV et al: Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP. Structure 2003;11:691-701.

 

Neiiendam JL et al: An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons. J Neurochem 2004;91:920-935.

 

Secher T et al: A neural cell adhesion molecule-derived fibroblast growth factor receptor agonist, the FGL-peptide, promotes early postnatal sensorimotor development and enhances social memory retention. Neuroscience 2006;141:1289-1299.

 

Skibo GG et al: A synthetic NCAM-derived peptide, FGL, protects hippocampal neurons from ischemic insult both in vitro and in vivo. Eur J Neurosci 2005;22:1589-1596.

 

Pokorny et al: Tolerability, Safety and Pharmacokinetics of the FGL, Peptide, A Novel mimetic of Neural Cell Adhesion Molecule, Following Intranasal Administration in Healthy Volunteer; Clin Pharmacokin 2007;46(4):351-8

 

Klementiev et al.: An NCAM-Derived peptide Reduces Neuropathological Signs and Cognitive Impairment Induced by A-beta 25-35. Neuroscience 2007 Mar 2;145(1):209-24.

 

Other compound specific literature

Klementiev B et al: A synthetic NCAM mimetic peptide, P2, facilitates recovery of cognitive and motor functions after traumatic brain injury. J.Neurol. 2006;253:II/90.

 

Petersen LG et al: IL-1beta-induced pro-apoptotic signalling is facilitated by NCAM/FGF receptor signalling and inhibited by the C3d ligand in the INS-1E rat beta cell line. Diabetologia 2006.

 

Li S et al: FGF-derived peptides: Functional agonists of the fibroblast growth factor receptor (FGFR). Accepted for publication in J Neurochem.